Hyperbaric Oxygen Therapy Conditions
Below is a partial list of what is considered “off-label” conditions that have shown to benefit from the use of hyperbaric oxygen therapy. These conditions have not yet received approval from the FDA and Health Canada, but are still showing substantial improvements with hyperbaric oxygen therapy.
Anoxia and Hypoxia: Near hanging, Birth injury, Smoke inhalation
Autism & Developmental Delays
Cancer immune support
Cerebral Palsy (CP)
Complex Regional Pain Syndrome (CRPS)
Cortical Visual Impairment
Cranial Nerve Syndromes: Bell's Palsy, Retinal artery occlusion, Trigeminal Neuralgia
Reflex Sympathetic Dystrophy (RSD)
Traumatic Brain Injury (TBI)
Sports Performance Enhancement & Sports Injury
Brown Recluse Spider Bites
Spinal Cord Injury
Fetal Alcohol Syndrome (FAS)
Stroke (acute and chronic)
Irritable Bowel Disease
Multiple Sclerosis (MS)
Closed Head Injuries
Off-Label refers to the use of hyperbaric oxygen therapy for treatment indications that have not yet been approved by the FDA/Health Canada for marketing purposes. The FDA and Health Canada play a significant role in how hyperbaric oxygen therapy is used; from the type of hyperbaric machines to the indications/conditions approved
An indication will generally only receive approval by the FDA and Health Canada after it has passed rigorous studies, which include double blind studies that demonstrate a quantifiable degree of improvement in a specific condition.
The cost to conduct studies that would satisfy these governing bodies would cost millions of dollars. Dues to the fact that oxygen cannot be patented, profits made from the sale of oxygen are too small to pay for studies that would meet the FDA and Health Canada’s requirements.
The International Hyperbaric Medical Associations position on the “off-label” use of hyperbaric oxygen therapy treatments.